Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
5.05
+0.02 (0.40%)
At close: Nov 13, 2026, 4:00 PM EST
5.45
+0.40 (7.85%)
After-hours: Nov 13, 2026, 7:59 PM EST
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $319.27 million as of November 13, 2026. It is the 17,503rd most valuable company in the world and the 3,093rd biggest in the United States. Its market cap has decreased by 0.55% in one year.
Market Cap
319.27M
Enterprise Value
181.15M
1-Year Change
-0.55%
Global Rank
Country Rank
#3,093 United States
Category
ChartMarket Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $319.27M, a decrease of -64.45%. That is a compound annual growth rate of -31.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 319.27M | -40.55% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agenus | 326.68M |
| Ocugen | 325.87M |
| Scribe Therapeutics | 319.19M |
| Vicore Pharma Holding AB | 316.52M |
| Century Therapeutics | 315.07M |
| Turn Therapeutics | 314.86M |
| Evommune | 312.84M |
| Cabaletta Bio | 312.79M |